Biotech Losers: Inovio Pharmaceuticals (NYSEMKT:INO), Oncomed Pharmaceuticals (NASDAQ:OMED), Enzymotec (NASDAQ:ENZY), Veracyte Inc (NASDAQ:VCYT)

Inovio Pharmaceuticals, Inc. (NYSEMKT:INO) announced financial results for the quarter and year ended December 31, 2013. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -7.98% in last session and finished the day at $3.23. Traded volume was 10,401,414 million shares in the last session and the average volume of the stock remained 7.79 million shares. The beta of the stock remained 3.69. Inovio Pharmaceuticals Inc (NYSEMKT:INO) … Continue reading Biotech Losers: Inovio Pharmaceuticals (NYSEMKT:INO), Oncomed Pharmaceuticals (NASDAQ:OMED), Enzymotec (NASDAQ:ENZY), Veracyte Inc (NASDAQ:VCYT)

Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

An increase in European and U.S. sales helped Reliv International Inc. (NASDAQ:RELV) raise profits by a small amount in the fourth quarter. Reliv International, Inc (NASDAQ:RELV) stock performance was -11.60% in last session and finished the day at $2.03. Traded volume was 64,448.00million shares in the last session and the average volume of the stock remained 10.29K shares. The beta of the stock remained 1.35. … Continue reading Biotech Stocks Touching New Lows: Reliv International (NASDAQ:RELV), Can Fite Biopharma (NYSEMKT:CANF), Enzymotec (NASDAQ:ENZY), Pacific Biosciences (NASDAQ:PACB)

Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Over the past three years, using its in-silico discovery platform for predictive drug discovery (i.e. computer models and algorithms), Compugen Ltd. (USA) (NASDAQ:CGEN) has developed a hugely compelling drug Pipeline across several clinical areas. Compugen Ltd. (USA) (NASDAQ:CGEN) stock performance was -20.14% in last session and finished the day at $11.34. Traded volume was 22,668.00 shares in the last session and the average volume of … Continue reading Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

5 Stocks in Dramatic Moves: Goldcorp Inc. (NYSE:GG), Talisman Energy Inc. (NYSE:TLM), Enzymotec Ltd. (NASDAQ:ENZY), Willdan Group, Inc. (NASDAQ:WLDN), Staples, Inc. (NASDAQ:SPLS)

Goldcorp Inc. (NYSE:GG) has announced that one of its subsidiaries has inked an agreement for selling its 100% interest in Wharf Mine at Lead, SD, to Coeur Mining, Inc. (CDE). Goldcorp will receive $105 million in cash from the sale, subject to specific closing adjustments. Goldcorp Inc. (NYSE:GG) belongs to Basic Materials sector. Its net profit margin is -68.10% and weekly performance is 1.99%. On … Continue reading 5 Stocks in Dramatic Moves: Goldcorp Inc. (NYSE:GG), Talisman Energy Inc. (NYSE:TLM), Enzymotec Ltd. (NASDAQ:ENZY), Willdan Group, Inc. (NASDAQ:WLDN), Staples, Inc. (NASDAQ:SPLS)

Active Stocks : Vishay Intertechnology Inc. (NYSE:VSH), General Mills (NYSE:GIS), Quidel Corp. (NASDAQ:QDEL), Lockheed Martin Corporation (NYSE:LMT), Enzymotec Ltd. (NASDAQ:ENZY)

Vishay Intertechnology, Inc. (NYSE:VSH) today announced that its MC AT professional series of automotive thin film chip resistors is now AEC-Q200-qualified over its entire resistance range from 1 Ω to 1 MΩ. Designed to deliver stability under harsh environmental conditions in automotive and industrial applications, the Vishay Beyschlag devices offer high-temperature performance to +175 °C for 1,000 hours. Vishay Intertechnology Inc. (NYSE:VSH) belongs to Technology sector. Its … Continue reading Active Stocks : Vishay Intertechnology Inc. (NYSE:VSH), General Mills (NYSE:GIS), Quidel Corp. (NASDAQ:QDEL), Lockheed Martin Corporation (NYSE:LMT), Enzymotec Ltd. (NASDAQ:ENZY)

Biotech Bullish Stocks: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Enzymotec Ltd (NASDAQ:ENZY), bluebird bio Inc (NASDAQ:BLUE), Athersys, Inc. (NASDAQ:ATHX)

xBoston hedge fund manager Baupost Group grew its portfolio of U.S. stocks by17 percent to $4.14 billion in the first quarter, maintaining large positions in several companies, including Cambridge-based Idenix Pharmaceuticals Inc (NASDAQ:IDIX). Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was 6.06% in last session and finished the day at $6.03. Traded volume was 789,231 shares in the last session and the average volume of the … Continue reading Biotech Bullish Stocks: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Enzymotec Ltd (NASDAQ:ENZY), bluebird bio Inc (NASDAQ:BLUE), Athersys, Inc. (NASDAQ:ATHX)